The first-in-human clinical trial of iPSC-derived platelets (iPLAT1): Autologous transfusion to an aplastic anemia patient with alloimmune platelet transfusion refractoriness
The first-in-human clinical trial of iPSC-derived platelets (iPLAT1): Autologous transfusion to an aplastic anemia patient with alloimmune platelet transfusion refractoriness
复制标题
iPSC 衍生血小板 (iPLAT1) 的首次人体临床试验：对同种免疫血小板输注无效的再生障碍性贫血患者进行自体输血
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Naoshi Sugimoto
中科院分区：
文献类型：
--
作者：
Hiroki Miyachi;Hiroki Kiriyama;Nonoko Kawabata;Naoki Itokawa;Motohiko Oshima;Tsuyoshi Imasaki;Toshio Suda;Atsushi Iwama;Ryo Nitta;Eriko Nitta;Naoshi Sugimoto
